Edition:
United Kingdom

Allogene Therapeutics Inc (ALLO.OQ)

ALLO.OQ on NASDAQ Stock Exchange Global Select Market

23.40USD
19 Oct 2018
Change (% chg)

$-0.40 (-1.68%)
Prev Close
$23.80
Open
$23.88
Day's High
$24.34
Day's Low
$23.00
Volume
94,391
Avg. Vol
--
52-wk High
$27.62
52-wk Low
$21.67

Chart for

About

Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogeneic chimeric antigen receptor (CAR) T cell product candidates utilizing protein... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  ALLO.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -- -- --
ROI: -- 0.45 14.28
ROE: -- 1.37 16.00

Earnings vs. Estimates

No consensus analysis data available.